glucocorticoid-remediable aldosteronism
| HPO ID | HPO Term |
|---|---|
| HP:0002315 | Headache |
| HP:0001324 | Muscle weakness |
| HP:0011739 | Dexamethasone-suppressible primary hyperaldosteronism |
| HP:0000421 | Epistaxis |
| HP:0008221 | Adrenal hyperplasia |
| HP:0002018 | Nausea |
| HP:0000360 | Tinnitus |
| HP:0002170 | Intracranial hemorrhage |
| HP:0011410 | Caesarian section |
| HP:0000822 | Hypertension |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025